Skip to Content

Stelara Sales Data

Rank 54 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Stelara U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 54 (8) 12.47% 11.11%
Q3 2013 62 (6) 7.67% 3.85%
Q2 2013 68 (13) 10.65% 8.33%
Q1 2013 81 (12) 10.71% 4.35%
Q4 2012 93 (7) 7.52% 4.55%
Q3 2012 100 ()

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
October 14, 2016Study Identifies Genetic Subtypes of Crohn's Disease
August 23, 2011Injectable Psoriasis Drugs May Not Hike Heart Risks: Study
January 13, 2010Newer Drug More Effective in Psoriasis Treatment
September 25, 2009Stelara Approved for Psoriasis
Hide